- IBM Watson Health announces that Teva Pharmaceutical Industries (NYSE:TEVA) is the first global pharma firm to sign on as a Foundational Life Sciences Partner for the Watson Health Cloud, a cognitive computing platform designed to process vast amounts of healthcare-related Big Data. It is an open development system that can interact in natural language instead of computer code.
- Teva will work with IBM on developing long-range solutions designed to collect and analyze real world data that will lead to new insights and inform a variety of initiatives such as reducing drug misuse and increasing prescribed medication adherence.